Results 121 to 130 of about 3,671,443 (301)

Average current mode controller for bridgeless PFC SEPIC converter with second-order model reduction operated in continuous conduction mode. [PDF]

PLoS One, 2023
Rai NA, Abdul Aziz MJ, Sahid MR, Husain AR, Anjum W, Low WY.   +5 more
europepmc   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

Molecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li, Shuichi Tatarano, Hirofumi Yoshino, Saeki Saito, Mitsuhiko Tominaga, Junya Arima, Ikumi Fukuda, Takashi Sakaguchi, Ryosuke Matsushita, Yasutoshi Yamada, Hideki Enokida   +10 more
wiley   +1 more source

Simplified Nonlinear Current-Mode Control of DC-DC Cuk Converter for Low-Cost Industrial Applications. [PDF]

Sensors (Basel), 2023
Al-Baidhani H, Kazimierczuk MK.
europepmc   +1 more source

Current-mode singleton fuzzy controller [PDF]

, 1994
This paper describes the realization of a fuzzy controller which implements the simplified inference mechanism. CMOS analog circuits where signals are represented as currents are employed.
Baturone Castillo, María Iluminada, Huertas Díaz, José Luis, Sánchez Solano, Santiago   +2 more
core  

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Expert knowledge-based peak current mode control of electrosurgical generators for improved output power regulation. [PDF]

J Electr Bioimpedance, 2023
Rafiq MM, Ibeas A, Ullah N.
europepmc   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source

Systematic Analysis of Driving Modes and NiFe Layer Thickness in Planar Hall Magnetoresistance Sensors

Sensors
Planar Hall magnetoresistance (PHMR) sensors are widely utilized due to their high sensitivity, simple structure, and cost-effectiveness. However, their performance is influenced by both the driving mode and the thickness of the ferromagnetic layer, yet ...
Changyeop Jeon, Mijin Kim, Jinwoo Kim, Sunghee Yang, Eunseo Choi, Byeonghwa Lim   +5 more
doaj   +1 more source

A resonant current-mode wireless power transfer for implantable medical devices: an overview. [PDF]

Biomed Eng Lett, 2022
Kim JH, Hassan NU, Lee SJ, Jung YW, Shin SU.   +4 more
europepmc   +1 more source